$USO: DAILY 1 YEAR VOLATILITY CHART into #Gilead says NIAID study of remdesivir as COVID-19 treatment met primary endpoint #COVID19 $AMZN $GOOGL $XLF $XOM $TSLA $GE $AMD $INTC  $TSLA https://t.co/ppQVER7XD0